The phase 3 trials will be conducted in 19 sites across 10 states, including in cities such as Delhi, Mumbai, Patna and Lucknow and would seek to enroll 28,500 volunteers aged 18 years and above.
In the fifth episode of 'Sunday Samvaad', the health minister also said the decision on emergency use authorisation for vaccines against the virus will depend on results of the clinical trials
CDSCO asks Bharat Biotech to submit complete immunogenicity data of Phase 2 trial of COVID-19 vaccine
The vaccine candidate, 'Covaxin', is being indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research
India's COVID-19 count crosses 56 lakh as 83,347 more test positive; Union minister Suresh Angadi dies of infection
India's coronavirus case count on Wednesday surged to 56,46,010 with 83,347 more testing positive since 8 am on Tuesday while the toll climbed to 90,020 with 1,085 more fatalities, according to the Union health ministry
Punjab CM Amarinder Singh gave stern directives about the poor not being pulled into trials without consent and understanding of the potential dangers.
Bharat Bio's COVAXIN: Ten takeaways from successful animal trials of the experimental COVID-19 vaccine
The animal trials demonstrate that COVAXIN protected against SARS-CoV-2, and amped up two kinds of antibodies needed for a strong immune response against the virus.
India records 83,809 new cases, COVID-19 tally crosses 49 lakh; 5 states account for 60% of active cases, says health ministry
India's COVID-19 caseload rose to 49,30,236 while the toll climbed to 80,776 with 1,054 people succumbing to the disease in 24 hours, the health ministry's data showed.
Coronavirus vaccine may hit Indian market by first quarter of 2021, says health minister Harsh Vardhan
Two homegrown vaccine candidates — Covaxin by Bharat Biotech and ZyCOV-D by Zydus Cadila — have almost finished the phase II clinical trials
Emerging landscape of COVID-19 vaccines in India, 14 Aug: Bharat Bio, Zydus move to Phase 2; Biological E, Bayor College tie up for COVID-19 vaccine
Over a dozen Indian companies are in partnership with other firms and institutes to bring a preventive vaccine into global markets by 2021.
Serum Institute of India has been chosen by Oxford University and its partner AstraZeneca to manufacture the COVID-19 vaccine
Over 3,500 volunteers have registered themselves for the trial at AIIMS this week, of whom the screening of 22 people is underway, doctors said
Covaxin, Bharat Biotech's COVID-19 vaccine candidate, has been developed in collaboration with the ICMR and NIV
Race for COVID-19 vaccine: Covaxin and ZyCoV-D begin human trials in India, Moderna publishes preliminary data from phase 1
While Covaxin is an inactivated whole-virion vaccine, ZyCoV-D is a DNA-plasmid based vaccine.
Indian pharma well-placed to develop, manufacture COVID-19 vaccine; but it must guard against rushing trials
Some experts told Firstpost that the government is willing to fast-track regulation, which is a risk they are willing to take, after completing "due protocols to check the safety of the drug"
COVAXIN controversy: Doctors in trial sites chosen by ICMR say human trials can’t be fast forwarded, anticipate 6-month observation period
Hyderabad-based Bharat Biotech received approval from the Central Drugs Standard Control Organisation (CDSCO) to begin human trials of COVAXIN last week. The vaccine has been developed in collaboration with the ICMR and National Institute of Virology in Pune.
Human trials of Indian COVID-19 vaccine candidates mark ‘beginning of pandemic’s end’, writes Vigyan Parisar scientist
Aiming to launch a COVID-19 vaccine by 15 August, ICMR had written to select medical institutions to expedite clinical trials for the candidate COVAXIN
PIB uploads article claiming none of six Indian companies working on COVID-19 vaccine will have it ready before 2021, later removes mention of year
The statement deleted from the article on PIB contradicted the Indian Council of Medical Research's plan to launch a vaccine by 15 August this year.
Day after ICMR's clarification on coronavirus vaccine, IASc calls timeline 'unprecedented and unfeasible'
A day after the ICMR announced that it aims to launch a COVID-19 vaccine by 15 August, it issued a clarification saying the process to expedite trials was in accordance with norms
While the ICMR has said it is important to expedite the clinical trials for a promising indigenous vaccine in the public interest and that all other vaccine candidates across the globe have been similarly fast-tracked, scientists in one voice have cautioned against being over-optimistic
Coronavirus Updates: Confirmed cases in Maharashtra cross two lakh with 7,074 new infections reported today; toll reaches 8,671
Coronavirus Updates: According to a state health department bulletin, over 1.98 lakh patients have been discharged till date and the recovery rate stands at 54.02 percent